Skip to content

Long-term outcome of childhood bacterial meningitis

The Dutch 20|30 Postmeningitis study protocol: a cross-sectional follow-up study of a historical childhood meningitis cohort on long-term outcome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27920
Enrollment
379
Registered
2017-12-09
Start date
2018-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health-related quality of life Social participation Cognitive functioning Hearing impairment Behavioural disfunctioning Medical care consumption Economic self-sufficiency

Interventions

The participants are invited cross-sectionally and to complete the following online internet-based questionnaires: - PROMIS Global Health 10 - PROMIS-29 Profile - PROMIS Satisfaction 2.0 - Weis

Sponsors

VU Medical Center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children were included at baseline when the causing pathogen of bacterial meningitis was Neisseria meningitides, Streptococcus pneumoniae, Streptococcus agalactiae, Escherichia coli or Listeria monocytogenes. Currently, the mean age of the first cohort will be 26 years (± 2.3 SD, range 22.0-31.0) and the mean age of the second cohort will be 19,7 years (± 1,89 SD, range 16.0-24.0)

Exclusion criteria

Exclusion criteria: Children in the original cohorts were excluded when they were infected by Hib or other less common pathogens. Furthermore, children with ‘complex onset’ of meningitis (defined as: meningitis secondary to immunodeficiency states, central nervous system surgery, cranial trauma or cerebrospinal fluid shunt infections or relapsing meningitis) were excluded. Moreover, because the intention was to study the more subtle neuropsychological sequelae, children having cognitive or behavioural problems prior to meningitis, children or adolescents in whom severe cognitive disabilities (a ‘specialist’s diagnosis’ of mental retardation or pervasive developmental disorder) were diagnosed before or after meningitis were excluded and will be excluded in the present study.

Design outcomes

Primary

MeasureTime frame
Health-related quality of life (considered aberrant if PROMIS Global Health 10 and PROMIS-29 Profile scored < 50)

Secondary

MeasureTime frame
- Subjective hearing (divided in groups with severe hearing disability, moderate hearing disability and very little hearing disability) - Executive functioning (clinically aberrant score >60) - Behavioural and adaptive functioning (scores of ASR will be compared to norms, descriptive statistics will be performed on the Weiss functional impairment rating scale self-report) - Economic self-sufficiency (based on scores of the iMTA productivity questionnaire) - Medical care consumption (based on scores of the iMTA Medical Consumption Questionnaire) - Academic achievement

Contacts

Public ContactO. El Tahir
o.tahir@vumc.nl+31(0)629391824

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)